Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.


Tecan Journal

Selected category: Cancer

Back to overview

Partnering for progress in oncology

Tecan recently teamed up with Nature Medicine to host a symposium on the latest ground-breaking research into cancer diagnosis and treatment, from novel biomarkers to personalized vaccines and cell-based therapies. A select group of industry leaders and key experts in oncology came together for a two-day event in Boston, Massachusetts, to accelerate research and clinical discoveries through better partnering between industry and academia. This summit highlighted Tecan’s dedication to assembling leaders in cancer – along with technologists, vendors and solutions providers – so they can share knowledge and expertise, and work collaboratively to battle cancer.

Read more

Non-invasive screening tests for preventive healthcare

Aqsens Health is focused on developing non-invasive screening and diagnostic tests based on enhanced time-resolved fluorescence for health monitoring and detection of serious diseases, such as cancer, where early diagnosis is vital. With an increasing workload, the company has turned to automation to allow higher throughput and rapid delivery of high quality results.

Read more

Sensing success

Spanish company Advanced Wave Sensors (AWSensors) is playing a key role in the pan-European Horizon 2020 LiqBiopSens and Catch-U-DNA projects to develop a new liquid biopsy platform for the early detection of colorectal and lung cancers. An important part of this process was the creation of a liquid handling platform incorporating an acoustic wave sensor array and microfluidic technology for the analysis of biomarkers in blood.

Read more